CHLAMYDIA IGG ELISA TEST SYSTEM— 510(k) K033079

Name: FDA 510(k) clearance K033079
Creator: U.S. Food and Drug Administration
Published: 2003-11-26

Substantially Equivalent

Trinity Biotech USA

FDA 510(k) clearance K033079 for CHLAMYDIA IGG ELISA TEST SYSTEM, Substantially Equivalent on 2003-11-26. Applicant: Trinity Biotech USA. Device class: 1.

Clearance details

Applicant: Trinity Biotech USA
Product code: Code LJC
Device class: Class 1
Regulation: 21 CFR 866.3120
Advisory panel: Microbiology
Date received: 2003-09-29
Decision date: 2003-11-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Jamestown, NY, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LJC

view all

K032330 — CT OIA2004-03-02
K033865 — IDEIA PCE CHLAMYDIA2004-01-21
K982210 — MODIFICATION OF SYVA MICROTRAK II CHLAMYDIA EIA1998-07-09
K962558 — CHLAMYDIA IGG ELISA TEST SYSTEM1997-02-24
K960850 — ACCESS CHLAMYDIA ASSAY1997-02-04

More clearances from Trinity Biotech USA

view all

K140455 — CAPTIA MEASLES IGM2014-05-22
K033105 — CAPTIA HSV 1 IGG TYPE SPECIFIC ELISA KIT2004-07-13
K033106 — CAPTIA HSV 2 IGG TYPE SPECIFIC ELISA KIT2004-07-13
K033051 — LEGIONELLA PNEUMOPHILA IGG/IGM2003-11-26
K033064 — MYCOPLASMA IGG2003-11-26

Data sourced from openFDA. This site is unofficial and independent of the FDA.